Literature DB >> 8848527

Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

E Fdez Espejo1, M Cador, L Stinus.   

Abstract

The intensity of opiate withdrawal syndrome in rats is usually quantified on the basis of selected physical signs or global scores. However, the selection criteria of signs and scores have not been subjected to an ethological discussion, hence they appear to be somewhat arbitrary. The objectives of this study were thus: i) to analyse the rat's behaviour during the naloxone-precipitated morphine withdrawal syndrome, ii) to evaluate the validity of classic methods, and iii) to design a new "etho-score". Ten rats were implanted with morphine pellets (75 mg x 2, SC), all receiving different naloxone doses following a within-subject design (0, 0.01, 0.05, 0.1, 0.5, 1 mg/kg SC). Twenty unexperienced rats and 20 with placebo pellets were injected with either saline or naloxone. Behaviour was videotaped and later analysed by computer-based ethological techniques. The ethogram encompassed 16 patterns displayed by rats during morphine withdrawal. Frequency, duration and latency of each pattern was measured, and a cluster analysis allowed discerning the structure of behaviour. Several physical signs and the Gellert-Holtzman score were also evaluated. The data revealed that writhing responses linearly changed in a dose-related fashion, and mastication was also enhanced after naloxone. Wet-dog shakes and jumping changed following an U-shaped curve. Significant changes in weight loss were found to be dose-dependent, and highly correlated to diarrhea. Learning effects were found to reliably affect exploration, writhing responses and some physical signs. The Gellert-Holtzman score was gradually enhanced after naloxone, being affected by learning as well. Naloxone affected lying and self-care responses in placebo rats. To sum up, the data indicated that: i) classic signs are useful, although most of them are disrupted by high naloxone or affected by learning effects, ii) the Gellert-Holtzman score was validated in this study, and iii) mastication and weight loss are good indicators of naloxone-precipitated morphine withdrawal, representing the basis of an "etho-score" which is herein proposed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8848527     DOI: 10.1007/bf02246086

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Modulatory actions of benzodiazepine receptor ligands on agonistic behaviour.

Authors:  J Mos; B Olivier; A M van der Poel
Journal:  Physiol Behav       Date:  1987

Review 2.  Precipitated morphine withdrawal in rats as a tool in opiate research.

Authors:  J Bläsig; A Herz
Journal:  Curr Dev Psychopharmacol       Date:  1977

3.  Effects of septal lesions on inter- and intraspecies aggression in rats.

Authors:  K A Miczek; S P Grossman
Journal:  J Comp Physiol Psychol       Date:  1972-04

4.  Stress produces opioid-like effects on investigatory behavior.

Authors:  A F Arnsten; C Berridge; D S Segal
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

5.  Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal.

Authors:  G F Koob; T L Wall; F E Bloom
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

Authors:  D H Malin; J R Lake; D E Fowler; M V Hammond; S L Brown; J E Leyva; P E Prasco; T M Dougherty
Journal:  Peptides       Date:  1990 Mar-Apr       Impact factor: 3.750

7.  Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.

Authors:  R C Frederickson; C R Hewes; J W Aiken
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

8.  Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.

Authors:  L H Gold; L Stinus; C E Inturrisi; G F Koob
Journal:  Eur J Pharmacol       Date:  1994-02-21       Impact factor: 4.432

9.  Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

10.  Selective anti-aggressive properties of DU 27725: ethological analyses of intermale and territorial aggression in the male rat.

Authors:  B Olivier
Journal:  Pharmacol Biochem Behav       Date:  1981       Impact factor: 3.533

View more
  7 in total

Review 1.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

2.  Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.

Authors:  Ellen A Walker; Steven N Sterious
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice.

Authors:  Concepción Maldonado; Marta Rodríguez-Arias; María A Aguilar; José Miñarro
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

4.  Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

Authors:  Mark R Hutchinson; Susannah S Lewis; Benjamen D Coats; David A Skyba; Nicole Y Crysdale; Debra L Berkelhammer; Anita Brzeski; Alexis Northcutt; Christine M Vietz; Charles M Judd; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2008-10-04       Impact factor: 7.217

5.  The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release.

Authors:  Sondra T Bland; Mark R Hutchinson; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2009-02-03       Impact factor: 7.217

6.  Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine.

Authors:  Dusica Bajic; Mariano Soiza-Reilly; Allegra L Spalding; Charles B Berde; Kathryn G Commons
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  Liposome-Encapsulated Morphine Affords a Prolonged Analgesia While Facilitating Extinction of Reward and Aversive Memories.

Authors:  Victoria Gómez-Murcia; Bruno Ribeiro Do Couto; Juan C Gómez-Fernández; María V Milanés; María L Laorden; Pilar Almela
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.